James H. MacCabe

16.1k total citations · 2 hit papers
219 papers, 7.6k citations indexed

About

James H. MacCabe is a scholar working on Psychiatry and Mental health, Clinical Psychology and Philosophy. According to data from OpenAlex, James H. MacCabe has authored 219 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 165 papers in Psychiatry and Mental health, 48 papers in Clinical Psychology and 38 papers in Philosophy. Recurrent topics in James H. MacCabe's work include Schizophrenia research and treatment (157 papers), Bipolar Disorder and Treatment (47 papers) and Mental Health and Psychiatry (38 papers). James H. MacCabe is often cited by papers focused on Schizophrenia research and treatment (157 papers), Bipolar Disorder and Treatment (47 papers) and Mental Health and Psychiatry (38 papers). James H. MacCabe collaborates with scholars based in United Kingdom, United States and Ireland. James H. MacCabe's co-authors include Robin Murray, John Lally, Christina M. Hultman, Abraham Reichenberg, Sven Cnattingius, Mats Lambe, Fiona Gaughran, Anthony S. David, David Taylor and Arsime Demjaha and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Psychiatry.

In The Last Decade

James H. MacCabe

214 papers receiving 7.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antipsychotic medication in schizophrenia: a review

2015 365 citations John Lally, James H. MacCabe profile →
Preterm Birth and Psychiatric Disorders in Young Adult Life

2012 343 citations James H. MacCabe et al. profile →

Peers

Countries citing papers authored by James H. MacCabe

Since Specialization

Citations

This map shows the geographic impact of James H. MacCabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James H. MacCabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James H. MacCabe more than expected).

Fields of papers citing papers by James H. MacCabe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James H. MacCabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James H. MacCabe. The network helps show where James H. MacCabe may publish in the future.

Co-authorship network of co-authors of James H. MacCabe

This figure shows the co-authorship network connecting the top 25 collaborators of James H. MacCabe. A scholar is included among the top collaborators of James H. MacCabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James H. MacCabe. James H. MacCabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Response to clozapine in treatment resistant schizophrenia is related to alterations in regional cerebral blood flow 2024 ·SHILAP Revista de lepidopterología ·(unknown), Fernando Zelaya, Kyra-Verena Sendt, Grant McQueen, Amy Gillespie, John Lally, Oliver Howes, Gareth J. Barker, Philip McGuire, James H. MacCabe, Alice Egerton	0
2	Longitudinal changes in DNA methylation associated with clozapine use in treatment-resistant schizophrenia from two international cohorts 2024 ·Translational Psychiatry ·Amy Gillespie, Emma Walker, Eilís Hannon, Grant McQueen, Kyra-Verena Sendt, (unknown), John Lally, Cynthia Okhuijsen‐Pfeifer, Marte van der Horst, Alkomiet Hasan, Emma Dempster, Joe Burrage, Jan Bogers, Dan Cohen, Marco P. Boks, David Collier, Alice Egerton, Jurjen J. Luykx, Jonathan Mill, James H. MacCabe	3
3	Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaboration 2022 ·Neuropsychopharmacology ·Alice Egerton, (unknown), (unknown), J.F.W. Deakin, Richard Drake, Oliver Howes, Laura Kassoumeri, Sobia Khan, (unknown), Jane Lees, Shôn Lewis, (unknown), Edward Millgate, Ebenezer Oloyede, (unknown), (unknown), Aviv Segev, Kyra-Verena Sendt, James H. MacCabe	14
4	Ethnic inequalities in clozapine use among people with treatment-resistant schizophrenia: a retrospective cohort study using data from electronic clinical records 2022 ·Social Psychiatry and Psychiatric Epidemiology ·Daniela Fonseca de Freitas, (unknown), Giouliana Kadra-Scalzo, Megan Pritchard, Hitesh Shetty, Matthew Broadbent, Rashmi Patel, Johnny Downs, Aviv Segev, Mizanur Khondoker, James H. MacCabe, Kamaldeep Bhui, Richard D. Hayes	11
5	COVID-related hospitalization, intensive care treatment, and all-cause mortality in patients with psychosis and treated with clozapine 2022 ·European Neuropsychopharmacology ·Risha Govind, Daniela Fonseca de Freitas, Megan Pritchard, Mizanur Khondoker, James Teo, Robert Stewart, Richard D. Hayes, James H. MacCabe	5
6	Prescribing clozapine in the UK: Quality improvement issues identified by clinical audit 2022 ·Journal of Psychopharmacology ·Thomas R. E. Barnes, James H. MacCabe, John M. Kane, (unknown), (unknown), Carol Paton	3
7	Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia 2022 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Grant McQueen, Kyra-Verena Sendt, Amy Gillespie, (unknown), John Lally, Emily Hedges, Kelly Diederen, Oliver Howes, Gareth J. Barker, David J. Lythgoe, Matthew J. Kempton, Philip McGuire, James H. MacCabe, Alice Egerton	9
8	Using a statistical learning approach to identify sociodemographic and clinical predictors of response to clozapine 2022 ·Journal of Psychopharmacology ·Daniela Fonseca de Freitas, Giouliana Kadra-Scalzo, Deborah Agbedjro, Emma Francis, (unknown), Megan Pritchard, Hitesh Shetty, Aviv Segev, Cecilia Casetta, Sophie E. Smart, Johnny Downs, Søren Rahn Christensen, Nikolaj Bak, Bruce J. Kinon, Daniel Ståhl, James H. MacCabe, Richard D. Hayes	5
9	Clinical correlates of early onset antipsychotic treatment resistance 2022 ·Journal of Psychopharmacology ·Daniela Fonseca de Freitas, Deborah Agbedjro, Giouliana Kadra-Scalzo, Emma Francis, (unknown), Megan Pritchard, Hitesh Shetty, Aviv Segev, Cecilia Casetta, Sophie E. Smart, Anna Morris, Johnny Downs, Søren Rahn Christensen, Nikolaj Bak, Bruce J. Kinon, Daniel Ståhl, Richard D. Hayes, James H. MacCabe	4
10	Clozapine-induced myocarditis: electronic health register analysis of incidence, timing, clinical markers and diagnostic accuracy 2021 ·The British Journal of Psychiatry ·Aviv Segev, Ehtesham Iqbal, Theresa A. McDonagh, Cecilia Casetta, Ebenezer Oloyede, Susan Piper, Carla M. Plymen, James H. MacCabe	19
11	Demographic and clinical variables associated with response to clozapine in schizophrenia: a systematic review and meta-analysis 2021 ·Psychological Medicine ·(unknown), Edward Millgate, Alice Egerton, James H. MacCabe	24
12	Clozapine treatment and risk of severe COVID‐19 infection 2021 ·Acta Psychiatrica Scandinavica ·(unknown), Alma Sörberg Wallin, (unknown), Hugo Sjöqvist, James H. MacCabe, Johan Åhlén, Christina Dalman	10
13	The physical health and side-effect monitoring of patients prescribed clozapine: data from a clinical audit conducted in UK mental health services 2020 ·SHILAP Revista de lepidopterología ·Thomas R. E. Barnes, James H. MacCabe, John M. Kane, (unknown), Carol Paton	9
14	The association between neighbourhood characteristics and physical victimisation in men and women with mental disorders 2020 ·BJPsych Open ·Vishal Bhavsar, (unknown), Rashmi Patel, Hitesh Shetty, Sumithra Velupillai, Robert Stewart, Matthew Broadbent, James H. MacCabe, Jayati Das‐Munshi, Louise M. Howard	4
15	Clozapine treatment and risk of COVID-19 infection: retrospective cohort study 2020 ·The British Journal of Psychiatry ·Risha Govind, Daniela Fonseca de Freitas, Megan Pritchard, Richard D. Hayes, James H. MacCabe	64
16	Effect of single dose N-acetylcysteine administration on resting state functional connectivity in schizophrenia 2019 ·Psychopharmacology ·Grant McQueen, (unknown), John Lally, Anthony S. Gabay, Tracy Collier, David J. Lythgoe, Gareth J. Barker, James Stone, Philip McGuire, James H. MacCabe, Alice Egerton	11
17	Risk of readmission in patients with schizophrenia and schizoaffective disorder newly prescribed clozapine 2019 ·Journal of Psychopharmacology ·(unknown), Giouliana Kadra-Scalzo, Johnny Downs, Hitesh Shetty, James H. MacCabe, David Taylor, Robert Stewart, Chin‐Kuo Chang, Richard D. Hayes	22
18	Long‐term antipsychotic polypharmacy prescribing in secondary mental health care and the risk of mortality 2018 ·Acta Psychiatrica Scandinavica ·Giouliana Kadra-Scalzo, Robert Stewart, Hitesh Shetty, James H. MacCabe, Chin‐Kuo Chang, David Taylor, Richard D. Hayes	25
19	Reasons for discontinuing clozapine: A cohort study of patients commencing treatment 2016 ·Schizophrenia Research ·Sophie E. Legge, Marian L. Hamshere, Richard D. Hayes, Johnny Downs, Michael O’Donovan, Michael J. Owen, James Walters, James H. MacCabe	99
20	Optimizing Outcomes in Clozapine Rechallenge Following Neutropenia 2015 ·The Journal of Clinical Psychiatry ·Nicholas Meyer, Siobhan Gee, Eromona Whiskey, David Taylor, Aleksandar Mijović, Fiona Gaughran, Sukhwinder S. Shergill, James H. MacCabe	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact